These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22302197)

  • 1. Non-HLA antibodies to immunogenic epitopes predict the evolution of chronic renal allograft injury.
    Sigdel TK; Li L; Tran TQ; Khatri P; Naesens M; Sansanwal P; Dai H; Hsieh SC; Sarwal MM
    J Am Soc Nephrol; 2012 Apr; 23(4):750-63. PubMed ID: 22302197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
    Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detailed examination of HLA antibody development on renal allograft failure and function.
    Zhu L; Lee PC; Everly MJ; Terasaki PI
    Clin Transpl; 2008; ():171-87. PubMed ID: 19711514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation.
    Cardarelli F; Pascual M; Tolkoff-Rubin N; Delmonico FL; Wong W; Schoenfeld DA; Zhang H; Cosimi AB; Saidman SL
    Transpl Int; 2005 May; 18(5):532-40. PubMed ID: 15819801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
    Lee PC; Zhu L; Terasaki PI; Everly MJ
    Transplantation; 2009 Aug; 88(4):568-74. PubMed ID: 19696641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year outcome of isolated glomerulitis on 3-month protocol biopsies of donor HLA antibody negative patients.
    Buob D; Grimbert P; Glowacki F; Labalette M; Dufossé F; Nochy D; Copin MC; Boleslawski E; Noël C; Hazzan M
    Transpl Int; 2012 Jun; 25(6):663-70. PubMed ID: 22487459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo production of donor-specific anti-HLA alloantibodies in early acute humoral renal allograft rejection.
    Spriewald BM; Hugo C
    Clin Transpl; 2006; ():469-72. PubMed ID: 18365405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
    Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
    Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential immunogenicity and clinical relevance of kidney compartment specific antigens after renal transplantation.
    Li L; Sigdel T; Vitalone M; Lee SH; Sarwal M
    J Proteome Res; 2010 Dec; 9(12):6715-21. PubMed ID: 20923235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up.
    Lachmann N; Terasaki PI; Schönemann C
    Clin Transpl; 2006; ():171-99. PubMed ID: 18365377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.
    Hourmant M; Cesbron-Gautier A; Terasaki PI; Mizutani K; Moreau A; Meurette A; Dantal J; Giral M; Blancho G; Cantarovich D; Karam G; Follea G; Soulillou JP; Bignon JD
    J Am Soc Nephrol; 2005 Sep; 16(9):2804-12. PubMed ID: 16014742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation.
    Cox ST; Stephens HA; Fernando R; Karasu A; Harber M; Howie AJ; Powis S; Zou Y; Stastny P; Madrigal JA; Little AM
    Hum Immunol; 2011 Oct; 72(10):827-34. PubMed ID: 21664940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact.
    Seveso M; Bosio E; Ancona E; Cozzi E
    Contrib Nephrol; 2009; 162():87-98. PubMed ID: 19001816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
    Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
    Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
    Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation.
    Lachmann N; Niemann M; Reinke P; Budde K; Schmidt D; Halleck F; Pruß A; Schönemann C; Spierings E; Staeck O
    Am J Transplant; 2017 Dec; 17(12):3076-3086. PubMed ID: 28613392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.